Vanguard Fiduciary Trust
VYGR icon

Vanguard Fiduciary Trust’s Voyager Therapeutics VYGR Stock Holding History

Vanguard Fiduciary Trust’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
337,325
+39,003
+13% +$148K ﹤0.01% 2954
2026
Q1 		$1.15M Buy
+298,322
New +$1.17M ﹤0.01% 2852

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Fiduciary Trust's VYGR Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Voyager Therapeutics (VYGR) stake by 13% in Q2 2026, buying an estimated $148K and bringing the position to 337,325 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2954.

Vanguard Fiduciary Trust first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Vanguard Fiduciary Trust held 337,325 shares of Voyager Therapeutics worth $1.18M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 39,003 Voyager Therapeutics shares in Q2 2026, an estimated $148K.
  • Voyager Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2954 holding.
  • Vanguard Fiduciary Trust first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.